+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Therapeutics Market 2024-2028

  • PDF Icon

    Report

  • 183 Pages
  • March 2024
  • Region: Global
  • TechNavio
  • ID: 5769594
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cardiovascular therapeutics market is forecasted to grow by USD 24.25 mn during 2023-2028, accelerating at a CAGR of 4.57% during the forecast period. The report on the cardiovascular therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing risk factors for cardiovascular diseases, the availability of advanced diagnostic methods, and the rising prevalence of hypercholesterolemia.

The cardiovascular therapeutics market is segmented as below:

By Distribution Channel

  • Hospital pharmacy
  • Retail Pharmacy
  • Online pharmacy

By Type

  • Antithrombotic drugs
  • Hypolipidemic drugs
  • Others

By Geographical Landscape

  • Asia
  • North America
  • Europe
  • Rest of World (ROW)
This study identifies the advent of novel oral anticoagulants (NOACS) as one of the prime reasons driving the cardiovascular therapeutics market growth during the next few years. Also, the identification of new pathogenic targets related to cardiovascular diseases and the strong incidence of coronary heart disease (CHD) worldwide will lead to sizable demand in the market.

The report on the cardiovascular therapeutics market covers the following areas:

  • Cardiovascular therapeutics market sizing
  • Cardiovascular therapeutics market forecast
  • Cardiovascular therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cardiovascular therapeutics market vendors that include Abbott Laboratories, Acutus Medical Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Viatris Inc., Aurobindo Pharma Ltd., and Dr Reddys Laboratories Ltd.. Also, the cardiovascular therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global industrial automation services market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global industrial automation services market 2018 - 2022 ($ billion)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 PE - Market size and forecast 2023-2028
Exhibit 34: Chart on PE - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on PE - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on PE - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on PE - Year-over-year growth 2023-2028 (%)
6.4 Maintenance and support - Market size and forecast 2023-2028
Exhibit 38: Chart on Maintenance and support - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Maintenance and support - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Maintenance and support - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Maintenance and support - Year-over-year growth 2023-2028 (%)
6.5 OS - Market size and forecast 2023-2028
Exhibit 42: Chart on OS - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on OS - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on OS - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on OS - Year-over-year growth 2023-2028 (%)
6.6 Consulting - Market size and forecast 2023-2028
Exhibit 46: Chart on Consulting - Market size and forecast 2023-2028 ($ billion)
Exhibit 47: Data Table on Consulting - Market size and forecast 2023-2028 ($ billion)
Exhibit 48: Chart on Consulting - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Consulting - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Type
Exhibit 50: Market opportunity by Type ($ billion)
Exhibit 51: Data Table on Market opportunity by Type ($ billion)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 52: Chart on End-user - Market share 2023-2028 (%)
Exhibit 53: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 54: Chart on Comparison by End-user
Exhibit 55: Data Table on Comparison by End-user
7.3 Discrete industries - Market size and forecast 2023-2028
Exhibit 56: Chart on Discrete industries - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Discrete industries - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Discrete industries - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Discrete industries - Year-over-year growth 2023-2028 (%)
7.4 Process industries - Market size and forecast 2023-2028
Exhibit 60: Chart on Process industries - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Process industries - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Process industries - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Process industries - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by End-user
Exhibit 64: Market opportunity by End-user ($ billion)
Exhibit 65: Data Table on Market opportunity by End-user ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 APAC - Market size and forecast 2023-2028
Exhibit 71: Chart on APAC - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on APAC - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on APAC - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on APAC - Year-over-year growth 2023-2028 (%)
9.4 North America - Market size and forecast 2023-2028
Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.5 Europe - Market size and forecast 2023-2028
Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.6 Middle East and Africa - Market size and forecast 2023-2028
Exhibit 83: Chart on Middle East and Africa - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Middle East and Africa - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Middle East and Africa - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Middle East and Africa - Year-over-year growth 2023-2028 (%)
9.7 South America - Market size and forecast 2023-2028
Exhibit 87: Chart on South America - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on South America - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on South America - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on South America - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 US - Market size and forecast 2023-2028
Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
9.10 Japan - Market size and forecast 2023-2028
Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.11 Germany - Market size and forecast 2023-2028
Exhibit 103: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.12 UK - Market size and forecast 2023-2028
Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.13 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 ABB Ltd.
Exhibit 119: ABB Ltd. - Overview
Exhibit 120: ABB Ltd. - Business segments
Exhibit 121: ABB Ltd. - Key news
Exhibit 122: ABB Ltd. - Key offerings
Exhibit 123: ABB Ltd. - Segment focus
12.4 Dwyer Instruments LLC
Exhibit 124: Dwyer Instruments LLC - Overview
Exhibit 125: Dwyer Instruments LLC - Product / Service
Exhibit 126: Dwyer Instruments LLC - Key offerings
12.5 Emerson Electric Co.
Exhibit 127: Emerson Electric Co. - Overview
Exhibit 128: Emerson Electric Co. - Business segments
Exhibit 129: Emerson Electric Co. - Key news
Exhibit 130: Emerson Electric Co. - Key offerings
Exhibit 131: Emerson Electric Co. - Segment focus
12.6 Fuji Electric Co. Ltd.
Exhibit 132: Fuji Electric Co. Ltd. - Overview
Exhibit 133: Fuji Electric Co. Ltd. - Business segments
Exhibit 134: Fuji Electric Co. Ltd. - Key offerings
Exhibit 135: Fuji Electric Co. Ltd. - Segment focus
12.7 General Electric Co.
Exhibit 136: General Electric Co. - Overview
Exhibit 137: General Electric Co. - Business segments
Exhibit 138: General Electric Co. - Key offerings
Exhibit 139: General Electric Co. - Segment focus
12.8 Hitachi Ltd.
Exhibit 140: Hitachi Ltd. - Overview
Exhibit 141: Hitachi Ltd. - Business segments
Exhibit 142: Hitachi Ltd. - Key news
Exhibit 143: Hitachi Ltd. - Key offerings
Exhibit 144: Hitachi Ltd. - Segment focus
12.9 Honeywell International Inc.
Exhibit 145: Honeywell International Inc. - Overview
Exhibit 146: Honeywell International Inc. - Business segments
Exhibit 147: Honeywell International Inc. - Key news
Exhibit 148: Honeywell International Inc. - Key offerings
Exhibit 149: Honeywell International Inc. - Segment focus
12.10 Mitsubishi Electric Corp.
Exhibit 150: Mitsubishi Electric Corp. - Overview
Exhibit 151: Mitsubishi Electric Corp. - Business segments
Exhibit 152: Mitsubishi Electric Corp. - Key news
Exhibit 153: Mitsubishi Electric Corp. - Key offerings
Exhibit 154: Mitsubishi Electric Corp. - Segment focus
12.11 OMRON Corp.
Exhibit 155: OMRON Corp. - Overview
Exhibit 156: OMRON Corp. - Business segments
Exhibit 157: OMRON Corp. - Key news
Exhibit 158: OMRON Corp. - Key offerings
Exhibit 159: OMRON Corp. - Segment focus
12.12 Parker Hannifin Corp.
Exhibit 160: Parker Hannifin Corp. - Overview
Exhibit 161: Parker Hannifin Corp. - Business segments
Exhibit 162: Parker Hannifin Corp. - Key news
Exhibit 163: Parker Hannifin Corp. - Key offerings
Exhibit 164: Parker Hannifin Corp. - Segment focus
12.13 Robert Bosch GmbH
Exhibit 165: Robert Bosch GmbH - Overview
Exhibit 166: Robert Bosch GmbH - Business segments
Exhibit 167: Robert Bosch GmbH - Key news
Exhibit 168: Robert Bosch GmbH - Key offerings
Exhibit 169: Robert Bosch GmbH - Segment focus
12.14 Rockwell Automation Inc.
Exhibit 170: Rockwell Automation Inc. - Overview
Exhibit 171: Rockwell Automation Inc. - Business segments
Exhibit 172: Rockwell Automation Inc. - Key news
Exhibit 173: Rockwell Automation Inc. - Key offerings
Exhibit 174: Rockwell Automation Inc. - Segment focus
12.15 Schneider Electric SE
Exhibit 175: Schneider Electric SE - Overview
Exhibit 176: Schneider Electric SE - Business segments
Exhibit 177: Schneider Electric SE - Key news
Exhibit 178: Schneider Electric SE - Key offerings
Exhibit 179: Schneider Electric SE - Segment focus
12.16 Siemens AG
Exhibit 180: Siemens AG - Overview
Exhibit 181: Siemens AG - Business segments
Exhibit 182: Siemens AG - Key news
Exhibit 183: Siemens AG - Key offerings
Exhibit 184: Siemens AG - Segment focus
12.17 Yokogawa Electric Corp.
Exhibit 185: Yokogawa Electric Corp. - Overview
Exhibit 186: Yokogawa Electric Corp. - Business segments
Exhibit 187: Yokogawa Electric Corp. - Key offerings
Exhibit 188: Yokogawa Electric Corp. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 189: Inclusions checklist
Exhibit 190: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 191: Currency conversion rates for US$
13.4 Research methodology
Exhibit 192: Research methodology
Exhibit 193: Validation techniques employed for market sizing
Exhibit 194: Information sources
13.5 List of abbreviations
Exhibit 195: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global cardiovascular therapeutics market market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Distribution Channel
Exhibits 33: Data Table on Comparison by Distribution Channel
Exhibits 34: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Retail Pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Retail Pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Retail Pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Retail Pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by Distribution Channel ($ million)
Exhibits 47: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 48: Chart on Type - Market share 2023-2028 (%)
Exhibits 49: Data Table on Type - Market share 2023-2028 (%)
Exhibits 50: Chart on Comparison by Type
Exhibits 51: Data Table on Comparison by Type
Exhibits 52: Chart on Antithrombotic drugs - Market size and forecast 2023-2028 ($ million)
Exhibits 53: Data Table on Antithrombotic drugs - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Chart on Antithrombotic drugs - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Antithrombotic drugs - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Hypolipidemic drugs - Market size and forecast 2023-2028 ($ million)
Exhibits 57: Data Table on Hypolipidemic drugs - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Chart on Hypolipidemic drugs - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Hypolipidemic drugs - Year-over-year growth 2023-2028 (%)
Exhibits 60: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 61: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 64: Market opportunity by Type ($ million)
Exhibits 65: Data Table on Market opportunity by Type ($ million)
Exhibits 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 69: Chart on Geographic comparison
Exhibits 70: Data Table on Geographic comparison
Exhibits 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits 96: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on Russia - Market size and forecast 2023-2028 ($ million)
Exhibits 100: Data Table on Russia - Market size and forecast 2023-2028 ($ million)
Exhibits 101: Chart on Russia - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on Russia - Year-over-year growth 2023-2028 (%)
Exhibits 103: Chart on Mexico - Market size and forecast 2023-2028 ($ million)
Exhibits 104: Data Table on Mexico - Market size and forecast 2023-2028 ($ million)
Exhibits 105: Chart on Mexico - Year-over-year growth 2023-2028 (%)
Exhibits 106: Data Table on Mexico - Year-over-year growth 2023-2028 (%)
Exhibits 107: Market opportunity By Geographical Landscape ($ million)
Exhibits 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 109: Impact of drivers and challenges in 2023 and 2028
Exhibits 110: Overview on Criticality of inputs and Factors of differentiation
Exhibits 111: Overview on factors of disruption
Exhibits 112: Impact of key risks on business
Exhibits 113: Vendors covered
Exhibits 114: Matrix on vendor position and classification
Exhibits 115: Abbott Laboratories - Overview
Exhibits 116: Abbott Laboratories - Business segments
Exhibits 117: Abbott Laboratories - Key offerings
Exhibits 118: Abbott Laboratories - Segment focus
Exhibits 119: Astellas Pharma Inc. - Overview
Exhibits 120: Astellas Pharma Inc. - Product / Service
Exhibits 121: Astellas Pharma Inc. - Key news
Exhibits 122: Astellas Pharma Inc. - Key offerings
Exhibits 123: AstraZeneca PLC - Overview
Exhibits 124: AstraZeneca PLC - Product / Service
Exhibits 125: AstraZeneca PLC - Key news
Exhibits 126: AstraZeneca PLC - Key offerings
Exhibits 127: Aurobindo Pharma Ltd. - Overview
Exhibits 128: Aurobindo Pharma Ltd. - Product / Service
Exhibits 129: Aurobindo Pharma Ltd. - Key offerings
Exhibits 130: Bayer AG - Overview
Exhibits 131: Bayer AG - Business segments
Exhibits 132: Bayer AG - Key news
Exhibits 133: Bayer AG - Key offerings
Exhibits 134: Bayer AG - Segment focus
Exhibits 135: Boehringer Ingelheim International GmbH - Overview
Exhibits 136: Boehringer Ingelheim International GmbH - Business segments
Exhibits 137: Boehringer Ingelheim International GmbH - Key news
Exhibits 138: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 139: Boehringer Ingelheim International GmbH - Segment focus
Exhibits 140: Bristol Myers Squibb Co. - Overview
Exhibits 141: Bristol Myers Squibb Co. - Product / Service
Exhibits 142: Bristol Myers Squibb Co. - Key news
Exhibits 143: Bristol Myers Squibb Co. - Key offerings
Exhibits 144: Daiichi Sankyo Co. Ltd. - Overview
Exhibits 145: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits 146: Daiichi Sankyo Co. Ltd. - Key news
Exhibits 147: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits 148: Dr Reddys Laboratories Ltd. - Overview
Exhibits 149: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 150: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 151: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 152: Eli Lilly and Co. - Overview
Exhibits 153: Eli Lilly and Co. - Product / Service
Exhibits 154: Eli Lilly and Co. - Key news
Exhibits 155: Eli Lilly and Co. - Key offerings
Exhibits 156: GlaxoSmithKline Plc - Overview
Exhibits 157: GlaxoSmithKline Plc - Business segments
Exhibits 158: GlaxoSmithKline Plc - Key news
Exhibits 159: GlaxoSmithKline Plc - Key offerings
Exhibits 160: GlaxoSmithKline Plc - Segment focus
Exhibits 161: Johnson and Johnson Services Inc. - Overview
Exhibits 162: Johnson and Johnson Services Inc. - Business segments
Exhibits 163: Johnson and Johnson Services Inc. - Key news
Exhibits 164: Johnson and Johnson Services Inc. - Key offerings
Exhibits 165: Johnson and Johnson Services Inc. - Segment focus
Exhibits 166: Merck and Co. Inc. - Overview
Exhibits 167: Merck and Co. Inc. - Business segments
Exhibits 168: Merck and Co. Inc. - Key news
Exhibits 169: Merck and Co. Inc. - Key offerings
Exhibits 170: Merck and Co. Inc. - Segment focus
Exhibits 171: Pfizer Inc. - Overview
Exhibits 172: Pfizer Inc. - Product / Service
Exhibits 173: Pfizer Inc. - Key news
Exhibits 174: Pfizer Inc. - Key offerings
Exhibits 175: Viatris Inc. - Overview
Exhibits 176: Viatris Inc. - Business segments
Exhibits 177: Viatris Inc. - Key news
Exhibits 178: Viatris Inc. - Key offerings
Exhibits 179: Viatris Inc. - Segment focus
Exhibits 180: Inclusions checklist
Exhibits 181: Exclusions checklist
Exhibits 182: Currency conversion rates for US$
Exhibits 183: Research methodology
Exhibits 184: Validation techniques employed for market sizing
Exhibits 185: Information sources
Exhibits 186: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global cardiovascular therapeutics market: Abbott Laboratories, Acutus Medical Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Viatris Inc., Aurobindo Pharma Ltd., and Dr Reddys Laboratories Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the advent of novel oral anticoagulants (NOACS)."

According to the report, one of the major drivers for this market is the increasing risk factors for cardiovascular diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Acutus Medical Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson and Johnson Services Inc.
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Aurobindo Pharma Ltd.
  • Dr Reddys Laboratories Ltd.